Cawood R - Search Results

1

Cawood R, Hills T, Wong SL, Alamoudi AA, Beadle S, Fisher KD, Seymour LW. Cawood R, et al. Trends Mol Med. 2012 Sep;18(9):564-74. doi: 10.1016/j.molmed.2012.07.007. Epub 2012 Aug 21. Trends Mol Med. 2012. PMID: 22917663 Review.

2

Toward more effective gene delivery.

Chen HH, Cawood R, Seymour LW. Chen HH, et al. Among authors: cawood r. Genome Biol. 2008 Jan 18;9(1):301. doi: 10.1186/gb-2008-9-1-301. Genome Biol. 2008. PMID: 18226177 Free PMC article.

3

Cellular carriers or free viruses?

Seymour LW, Cawood R, Fisher KD. Seymour LW, et al. Among authors: cawood r. Curr Opin Mol Ther. 2008 Aug;10(4):321-2. Curr Opin Mol Ther. 2008. PMID: 18683095 No abstract available.

4

Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells.

Cawood R, Chen HH, Carroll F, Bazan-Peregrino M, van Rooijen N, Seymour LW. Cawood R, et al. PLoS Pathog. 2009 May;5(5):e1000440. doi: 10.1371/journal.ppat.1000440. Epub 2009 May 22. PLoS Pathog. 2009. PMID: 19461878 Free PMC article.

5

Blood compatibility of enveloped viruses.

Kueberuwa G, Cawood R, Seymour LW. Kueberuwa G, et al. Among authors: cawood r. Curr Opin Mol Ther. 2010 Aug;12(4):412-20. Curr Opin Mol Ther. 2010. PMID: 20677092 Review.

6

Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytia.

Chen HH, Cawood R, El-Sherbini Y, Purdie L, Bazan-Peregrino M, Seymour LW, Carlisle RC. Chen HH, et al. Among authors: cawood r. Mol Ther. 2011 Jan;19(1):67-75. doi: 10.1038/mt.2010.209. Epub 2010 Sep 28. Mol Ther. 2011. PMID: 20877345 Free PMC article.

7

MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.

Cawood R, Wong SL, Di Y, Baban DF, Seymour LW. Cawood R, et al. PLoS One. 2011 Jan 10;6(1):e16152. doi: 10.1371/journal.pone.0016152. PLoS One. 2011. PMID: 21264344 Free PMC article.

8

Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway.

Seki T, Carroll F, Illingworth S, Green N, Cawood R, Bachtarzi H, Subr V, Fisher KD, Seymour LW. Seki T, et al. Among authors: cawood r. J Control Release. 2011 Dec 20;156(3):381-9. doi: 10.1016/j.jconrel.2011.08.022. Epub 2011 Aug 22. J Control Release. 2011. PMID: 21884739

9

Virotherapy--cancer targeted pharmacology.

Tedcastle A, Cawood R, Di Y, Fisher KD, Seymour LW. Tedcastle A, et al. Among authors: cawood r. Drug Discov Today. 2012 Mar;17(5-6):215-20. doi: 10.1016/j.drudis.2011.12.011. Epub 2011 Dec 16. Drug Discov Today. 2012. PMID: 22198165 Review.

10

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.

Green NK, Hale A, Cawood R, Illingworth S, Herbert C, Hermiston T, Subr V, Ulbrich K, van Rooijen N, Seymour LW, Fisher KD. Green NK, et al. Among authors: cawood r. Nanomedicine (Lond). 2012 Nov;7(11):1683-95. doi: 10.2217/nnm.12.50. Epub 2012 Jun 18. Nanomedicine (Lond). 2012. PMID: 22709345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters